Therapeutic diet for pet sales will expand through 2036, with dogs holding 48.6% of the pet type segment in 2026. Gastrointestinal issues lead the indication segment with a 21.8% share. The market is projected to reach USD 540.8 million in 2026 and USD 800.52 million by 2036 across veterinary channels.